This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Innovations in Cancer Treatment by Kah Suan Lim
Introduction
Kah Suan Lim is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of cancer treatment, particularly in relation to BRCA1 and BRCA2 mutations. With a total of 2 patents, his work focuses on innovative methods that aim to improve patient outcomes in oncology.
Latest Patents
Kah Suan Lim's latest patents include groundbreaking methods for treating cancers associated with BRCA1 and/or BRCA2 mutations. One of his patents discloses methods for treating these cancers by administering an effective amount of a ubiquitin-specific protease 1 (USP1) inhibitor. This innovative approach has the potential to enhance therapeutic strategies for patients suffering from these specific types of cancer.
Career Highlights
Kah Suan Lim is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in cancer therapies. His work is characterized by a commitment to developing effective treatment options for patients with genetic predispositions to cancer.
Collaborations
Kah Suan Lim collaborates with notable professionals in the field, including Alan D D'Andrea. Their joint efforts contribute to the ongoing research and development of innovative cancer treatments.
Conclusion
Kah Suan Lim's contributions to cancer treatment through his patents and collaborations highlight the importance of innovation in medical research. His work continues to pave the way for advancements in oncology and patient care.